HDL oxidability and its protective effect against LDL oxidation in type 2 diabetic patients

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 14, Issue 1, 2001, Pages 27-36

  Sanguinetti, S M ^a   Brites, F D ^a   Fasulo, V ^a   Verona, J ^a   Elbert, A ^a   Wilkinski, R L W ^a   Schreier, L E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

High density lipoprotein; Lipoprotein oxidation; Low density lipoprotein; Paraoxonase; Type 2 diabetes

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; COPPER; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CHEMICAL COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HETEROZYGOSITY; HUMAN; INCUBATION TIME; ISOLATION PROCEDURE; MALE; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; PEROXIDATION; PHENOTYPE; PRIORITY JOURNAL; PROTECTION; PROTEIN STRUCTURE;

ADULT; AGED; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; COPPER; DIABETES MELLITUS, TYPE 2; ELECTROPHORESIS, AGAR GEL; ESTERASES; FEMALE; HUMANS; KINETICS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMIN E;

EID: 0035071115     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Beyond cholesterol: Modifications of low density lipoprotein that increase its atherogenicity
2. Modified forms of LDL and atherogenesis
3. Role of oxidized LDL in atherogenesis
4. Low density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease
5. Protection of low density lipoprotein against oxidative modification by high density lipoprotein associated paraoxonase
6. High density lipoprotein and lipoprotein oxidation
7. High density lipoprotein oxidation: In vitro susceptibility and potential in vivo consequences
8. High density associated enzymes: Their role in vascular biology
9. Does paraoxonase play a role in susceptibility to cardiovascular disease?
10. Protective effect of high density lipoprotein associated paraoxonase
11. Paraoxonase inhibits high density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase
12. Effects of dietary vitamin C and E supplementation on the copper mediated oxidation of HDL and on HDL mediated cholesterol efflux
13. Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by α-tocopherol
14. Oxidized low density lipoproteins: A role in the pathogenesis of atherosclerosis in diabetes
15. Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modification
16. Serum paraoxonase activity concentration and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins
17. Sequential flotation ultracentrifugation
18. Electrophoretic separation of plasma lipoproteins in agarose gel
19. 2
20. LDL (low density lipoprotein) cholesterol determination in blood serum following precipitation of LDL with poly(vinyl sulphate)
21. Phosphorus assay in column chromatography
22. Protein measurement with the folin phenol reagent
23. Measurement of antioxidants in human blood plasma
24. Detection of structural alterations in LDL isolated from type 2 diabetic patients: Application of the fructosamine assay to evaluate the extent of LDL glycation
25. Mechanistic and genetic aspects of susceptibility of LDL to oxidation
26. The role of high density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low density lipoprotein oxidation
27. HDL composition and HDL antioxidant capacity in patients on regular haemodialysis
28. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of cholpyrifos and parathion by plasma paraoxonase/arylesterase
29. The polymorphic paraoxonase/arylesterase isozymes of human serum
30. Paraoxonase genotypes, lipoprotein lipase activity, and HDL. Arterioscler
31. HDL, its enzymes and its potential to influence lipid peroxidatin
32. Tocopherol-mediated peroxidation of lipoproteins: Implications for vitamin E as a potential antiatherogenic supplement
33. α-tocopherol enrichment of high density lipoproteins: Stabilization of hydroperoxides produced during copper oxidation
34. Glycation, oxidation and lipoxidation in the development of diabetic complications
35. Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels
36. High density lipoprotein metabolism
37. Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may be due to the abnormal composition of HDL. Arterioscler
38. Effect of platelet activating factor acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein
39. Anti-inflammatory HDL becomes proinflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures
40. Hydrolysis and transesterification of platelet activating factor by lecithin cholesterol acyltransferase
41. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors
42. Exchange of oxidized cholesteryl ester transfer protein
43. Copper- and malondialdehyde-induced modification of high density lipoprotein and parallel loss of lecithin cholesterol acyltransferase activation
44. High density lipoprotein losses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification